MANAGEMENT OF ALCOHOL WITHDRAWAL IN A GENERAL HOSPITAL SETTING- CL PSYCHIATRY PERSPECTIVE R.HEWKO MD FRCPC CL PSYCHIATRIST

Slides:



Advertisements
Similar presentations
Alcohol: Research to Practice Gail D’Onofrio MD, MS Section of Emergency Medicine Yale University School of Medicine.
Advertisements

Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Best Practice Tom Shiffler, MD 7/23/10
Improving outcomes for older people: Monitoring and regulating standards Ann Close 8 th June 2011.
Rare Film Guide Slide Set. Clinical Trial Design for Pirfenidone Study Purpose of Study: To see if the use of pirfenidone decreases the loss of lung function.
Nallasamy K, Jayashree M, Singhi S, Bansal A
Community Alcohol Detoxification Dr Merlin Willcox, Luther St Medical Centre, Oxford.
UNMH Alcohol Withdrawal Protocol Based on and adapted from alcohol withdrawal protocol at Bayfront Medical Center CriticalCareNurse Vol 30, No. 3, June.
Farhiyo hassan Zabiti Omer
Rohit M. Jangi, MD Medical Director, Bethany Health Care Center
Transition of Care in patients with diabetes Medha Munshi, MD Joslin Diabetes Center Beth Israel Deaconess Medical Center Harvard Medical School.
Naturalistic Study: Treating the Acutely Agitated Patient Andrew Francis, MD, PhD Associate Professor State University of New York at Stony Brook Health.
Journal Club Alcohol and Health: Current Evidence November-December 2005.
Sedation of Patients for Nuclear Medicine and Radiographic Procedures Susan Weiss, CNMT Radiation Safety Officer The Children’s Memorial Medical Center.
Dose-Toxicity Study of Oral Prednisone in Ocular Myasthenia Michael Benatar, Mike McDermott, Gil Wolfe and Don Sanders.
Status Epilepticus (SE): Rx Following Benzodiazepine Use Edward Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois.
First Line Therapy in Acute Seizure Management William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert Wood Johnson University Hospital.
Emergency Psychiatry E. Prost. Outline 1. Emergency Room Assessment 2. Behavioural Emergencies: Assessment 3. Behavioural Emergencies: Interventions.
Alcohol Interventions: What the research tells us Professor Colin Drummond.
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial Journal Club 09/01/11 JAMA, February 4, 2009—Vol 301, No
Copyright Alcohol Medical Scholars Program1 SUBSTANCE USE DISORDERS IN GERIATRIC PATIENTS Steven H. Madonick, M.D. Yale University School of Medicine New.
Symptom-triggered Vs Fixed Dosing Schedules in the Management of Alcohol Withdrawal Jay Murdoch Alcohol Nurse Specialist.
Management of Alcohol Withdrawal
7: Managing withdrawal Objectives
ACEP Clinical Policy: ACEP Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures William C. Dalsey,
Inpatient and Outpatient Management of Alcohol Withdrawal Devang Gandhi, MD Robert Joel Bush, MD University of Maryland- Sheppard Pratt Addiction Medicine.
Inpatient Management of Alcohol Withdrawal
DR NIRANJAN P DR K LAKSHMAN DR M S SRIDHAR AUDIT ON DISCHARGE SUMMARIES.
Naturalistic Study: Treating the Acutely Agitated Patient Andrew Francis, MD, PhD.
Status epilepticus. Status Epilepticus Traditionally, SE is defined as continuous or repetitive seizure activity persisting for at least 30 minutes without.
Pain Agitation & Delirium SCCM Pain assessment i. We recommend that pain be routinely monitored in all adult ICU patients (+1B). ii. The Behavioral.
From screening into treatment: Implementation solutions for Alcoholism therapy Thomas R. Kosten MD JH Waggoner Chair and Professor of Psychiatry & Neuroscience.
Alcohol Withdrawal Resident Rounds July 10, 2007 Maggie Gordon, R2.
Toxicology for Medical Students
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
1 Ethical issues in clinical trials Bernard Lo, M.D. February 10, 2010.
Morbidity and Mortality report MICU Bliss 11I Veena Panduranga Juliana Alvarez-Argote.
Monthly Journal article review: Vimmi Kang PGY 2
Survey Methodology Four Point Scale Very SatisfiedSatisfiedDissatisfiedVery Dissatisfied.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
CE-1 IRESSA ® Clinical Efficacy Ronald B. Natale, MD Director Cedars Sinai Comprehensive Cancer Center Ronald B. Natale, MD Director Cedars Sinai Comprehensive.
Rapid Fire Journal Club May 16, 2014 Sadie T. Velásquez.
 Sally, a 33 year old legal secretary, is admitted to your ward after being involved in a MVA  She has a past history of poly drug use and last used.
Nursing Process: The Foundation for Safe and Effective Care Chapter 5.
Peter Coleman MD The Coleman Institute Richmond Va. USA.
Clinical Management Course: Medical Complications of Alcoholism Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology.
Elderly Frailty Project in Teesside
Liaison and Emergency Psychiatry Moray 1 Alcohol dependence and Safe Withdrawal In-patient detox in Dr Grays.
Mental Health and Addictions. Current State BMHC.
Iatrogenic Delirium Driver Diagram AIMPrimary Drivers Secondary Drivers Change Ideas Reduction incidence of Iatrogenic Delirium Early Identification &
Sanaz Sakiani, MD Endocrinology Fellow Journal Club
March 2016 ALCOHOL WITHDRAWAL.  Recognition of alcohol withdrawal symptoms  Ensuring appropriate treatment so that complications are prevented  Describing.
ALCOHOL WITHDRAWAL: PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT
Alcohol dependence and harmful alcohol use NICE quality standard August 2011.
Common Presentations Depression With or without suicidality Adjustment reactions Mania Psychosis Intoxication Withdrawal.
Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia: A Large Retrospective Study Tyler S. Kaster MD, Zafiris J.
INTRODUCTION Acute alcohol withdrawal syndrome occurs when individuals with alcohol dependency abruptly stop or substantially reduce their alcohol consumption.
Managing Alcohol and Opioid Withdrawals
 Discuss the symptoms and signs of alcohol withdrawal.  Discuss the management of alcohol withdrawal.
Audit on the Incidence of Alcohol Withdrawal Seizures in an Adult Drug and Alcohol Detoxification Unit CT3 psych: Dr Sun Supervisor: Dr Race Hafan Wen.
Alcohol and Other Drug Emergencies
ESETT Eligibility Overview
Analysis of Safety and Efficacy of Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal in ICU Vincent Rizzo MD MBA FACP Ricardo Lopez MD FCCP.
UCI internal medicine mini-lecture series By Julia Kao
Clinical pharmacology of sedative-hypnotics
Treatment of Alcohol Withdrawal in Hospitalized Patients
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Understanding and Using ASAM Criteria
Presentation transcript:

MANAGEMENT OF ALCOHOL WITHDRAWAL IN A GENERAL HOSPITAL SETTING- CL PSYCHIATRY PERSPECTIVE R.HEWKO MD FRCPC CL PSYCHIATRIST

DISCLOSURE NOTHING TO DISCLOSE

CL PSYCHIARTY ROLE ? PRIMARY MANAGMENT ? SECONDARY MANAGEMENT - FAILED PRIMARY SERVICE MANAGEMENT - CLEAN UP - DEPENDANT ON UNDERSTANDING PRIMARY SERVICE MODEL – CIWA PROTOCOL

CIWA MODEL -CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT - ALCOHOL - 9 ITEMS ASSESSED BY NURSING STAFF - LINKED TO A PREPRINTED ORDER SET - PRIMARY AGENTS - BENZODIAZPINES

CIWA PROTOCOL - ADVANTAGES EVIDENCE BASED PRACTICE REQUIRE LESS BENZO’S THAN FIXED DOSE MODELS CONSISTANT TREATMENT MINIMAL PHYSICIAN INVOVLEMENT PRIMARILY NURSING BASED CARE ONE SIZE FITS ALL

MAYO CLINIC ARTICLE TITLE – Inappropriate use of Symptom-Triggered Therapy for Alcohol Withdrawal in the General Hospital Authors – KA Hecksel, JM Bostwick, TM Jaeger Ref. Mayo Clin. Proc. 2008;83(3):

METHODOLOGY 124 OF 495 PATIENTS RX WITH CIWA PROTOCOL IN TWO MAYO CLINIC AFFILIATED HOSPTIALS RANDOM SELECTION ACCOUNTING FOR AGE/GENDER ADMISSION CRITERIA FOR CIWA PROTOCOL MALES - > 4 DRINKS /DAY WK PRIOR TO HOSP. FEMALES - > 2 DRINKS /DAY WK PRIOR TO HOSP. ABLE TO COMMUNICATE MEANINGFULLY

RESULTS 52 % - 64/124 OF PATIENTS RX DID NOT MEET INCLUSION CRITERIA 14 % - 9 PTS UNABLE TO COMMUNICATE 55 % - 35 PTS HAD NO RECENT ALCOHOL HX 31 % - 20 PTS MET NEITHER CRITERIA

CIWA DEVOPMENT AND VALIDATION PRIVATE HOSPITAL DETOX AGE < 60 YRS OLD PTS MEDICALLY CLEAR GEN. HOSPTIAL STUDIES EXCLUSION CRITERIA - AGE -SEVERITY OF ILLNESS

PREPRINTED ORDERS DEVELOPED BY ASAM PTS. IN A VA DETOX - 3 PTS OVER AGE 60 - PTS MEDICALLY CLEAR

CLINICAL LITERATURE – BENZODIAZEPINES AGENTS OF CHOICE META-ANALYSIS HOSPITAL BASED MANAGEMENT OF AW HOLBROOK,CMAJ,MAR 9, (5) COMPARITIVE STUDIES – BENZO’S. NEUROLEPTICS, ANTICONVULSANTS, CHLORAL HYDRATE BENZODIAZIPINES SAFE AND EFFECTIVE AGENT OF CHOICE FOR TREATMENT OF AW NO BENZODIAZEPINE SUPERIOR IN EFFICACY / SAFETY

LIMITATIONS 11 “GOOD” STUDIES N’s PATIENTS PER STUDY MEAN AGE STUDIES LTD PTS TO MILD ILLNESS ALL STUDIES EXCLUDED SEVERELY ILL

CIWA PROTOCAL ADVANTAGES = DISADVANTAGES EASE AND EFFICIENCY PHYSICIAN INVOLVEMENT “IDENTIFY” AT RISK PT INITIATE CIWA – TICK BOXES NURSING STAFF MANAGE THE PATIENT ON “AUTOPILOT” -ASSESS CIWA SCORE -GIVE BENZOS UNTIL SCORE < 10 MINIMAL ONGOING PHYSICIAN INVOLVEMENT

IMPLICATIONS CIWA PROTOCOL VALIDATED FOR RELATIVELY YOUNG, HEALTHY PTS PTS INAPPROPRIATELY STARTED INTO PROTOCOL MOST PHYSICIANS UNAWARE OF LIMITATIONS MINIMAL FORMAL TEACHING LIMITED PHYSICIAN MONITERING DELAYED RECOGNITION OF COMPLICATIONS POTENTIAL FOR SIGNIFICANT MORBIDITY/MORTALITY PSYCHIATRIC REFERRAL - ONGOING AGITATION / CONFUSION - DELIRIUM

DELIRIUM – ALCOHOL HX / SEQUELAE OF CIWA PROTOCOL DDX - DT’S 1/300 - DELIRIUM “OTHER” ETIOLOGY - BENZODIAZEPINE INTOXICATION - AW AND DELIRIUM OTHER ETIOLOGY - DELIRIUM AND BENZO INTOXICATION

ASSESSMENT/MANAGEMENT EVIDENCE / ABSENCE OF AUTONOMIC AROUSAL (AA) -AA CONTINUE BENZO’S ADD NEUROLEPTICS REG/PRN -DROWSY / MIN. AA - TAPER BENZO’S - TITRATE REG/PRN NEUROLEPTICS - NORMALIZE SLEEP - QUETIAPINE

AW - MAJOR AUTONOMIC AROUSAL REFRACTORY AW - AGGRESSIVE BENZO’S - LORAZEPAM 2-4 mg QIH PRN - REG. BENZO’S – LORAZEPAM / DIAZEPAM - HYPOMAGNESEMIA ?

HYPOMAGNESEMIA COMMON ISSUE IN PATIENTS AT RISK -MAJOR AW HYPOMAG. - INCR. RISK /SEVERITY OF AW - INCR. RISK SEIZURES / SEIZURE STATUS - REFRACTORY HYPOKALEMIA - REFRACTORY WITHDRAWAL? - BENZO INSENSITIVITY - ANIMAL STUDIES REPLACEMENT – 5 GMs IV Q12H/Q8H 3-6 DOSES

REFRACTORY DELIRIUM 42 Y/O MALE – ONGOING DELIRIUM DAY 4 – DROWSY/ DISORIENTED AVERAGING 10 mg LORAZEPAM LAST 2 DAYS CONFUSION/NYSTAGMOUS/ATAXIA DX ? RX ?

WERNICKE’S ENCEPHALOPATHY THIAMINE DEFICIENCY MEDICAL EMERGENCY 30 % NEUROLOGIC SEQUELAE EVEN WITH RX RX - THIAMINE -PARENTERAL IM/IV 100mg - AT LEAST 3 DAYS -RELIABLE UNTIL ORAL INTAKE

SUMMARY CIWA PROTOCOL NOT VALIDATED IN EDLERLY MEDICALLY COMPRISED OVERUSED WITH INADEQUATE ASSESSMENT LOSS OF CLINICAL SKILLS / JUDGEMENT SIGNIFICANT INCIDENCE RESIDUAL DELIRIUM A LAW SUIT WAITING TO HAPPEN !